These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21303300)

  • 21. [Near a biological diagnosis of Alzheimer's disease and related disorders].
    Krolak-Salmon P; Seguin J; Perret-Liaudet A; Desestret V; Vighetto A; Bonnefoy M
    Rev Med Interne; 2008 Oct; 29(10):785-93. PubMed ID: 18584921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer's disease.
    Rahmadi A; Steiner N; Münch G
    Clin Chem Lab Med; 2011 Mar; 49(3):385-91. PubMed ID: 21275816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical indications for analysis of Alzheimer's disease CSF biomarkers.
    Engelborghs S
    Rev Neurol (Paris); 2013 Oct; 169(10):709-14. PubMed ID: 24016466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of neurovascular unit damage in the occurrence and development of Alzheimer's disease.
    Liu X; Hou D; Lin F; Luo J; Xie J; Wang Y; Tian Y
    Rev Neurosci; 2019 Jul; 30(5):477-484. PubMed ID: 30530893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic Peripheral Biomarkers for Early Diagnosis of Alzheimer's Disease.
    Villa C; Stoccoro A
    Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 35893045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Luigi Amaducci memorial award winner's paper 2003. A neurologist's view of Alzheimer's disease and dementia.
    Katzman R
    Int Psychogeriatr; 2004 Sep; 16(3):259-73. PubMed ID: 15559752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers.
    Reitz C; Mayeux R
    Biochem Pharmacol; 2014 Apr; 88(4):640-51. PubMed ID: 24398425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Next-generation biomarker discovery in Alzheimer's disease using metabolomics - from animal to human studies.
    Hurtado MO; Kohler I; de Lange EC
    Bioanalysis; 2018 Sep; 10(18):1525-1546. PubMed ID: 30198770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detecting Alzheimer's disease biomarkers: From antibodies to new bio-mimetic receptors and their application to established and emerging bioanalytical platforms - A critical review.
    Scarano S; Lisi S; Ravelet C; Peyrin E; Minunni M
    Anal Chim Acta; 2016 Oct; 940():21-37. PubMed ID: 27662756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alzheimer's disease a century later.
    Caselli RJ; Beach TG; Yaari R; Reiman EM
    J Clin Psychiatry; 2006 Nov; 67(11):1784-800. PubMed ID: 17196061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. When Does Alzheimer's Disease Really Start? The Role of Biomarkers.
    Lloret A; Esteve D; Lloret MA; Cervera-Ferri A; Lopez B; Nepomuceno M; Monllor P
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31698826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical utility and applicability of biomarker-based diagnostic criteria for Alzheimer's disease: a BeDeCo survey.
    Bier JC; Verschraegen J; Vandenberghe R; Guillaume B; Picard G; Otte G; Mormont E; Gilles C; Segers K; Sieben A; Thiery E; Ventura M; De Deyn P; Deryck O; Versijpt J; Salmon E; Engelborghs S; Ivanoiu A
    Acta Neurol Belg; 2015 Dec; 115(4):547-55. PubMed ID: 25576445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical aspects of Alzheimer's disease.
    Zvěřová M
    Clin Biochem; 2019 Oct; 72():3-6. PubMed ID: 31034802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical and Radiological Markers of Alzheimer's Disease Progression.
    Dziedzic T; Pera J; Klimkowicz-Mrowiec A; Mroczko B; Slowik A
    J Alzheimers Dis; 2016; 50(3):623-44. PubMed ID: 26757184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DASH and Mediterranean-type Dietary Patterns to Maintain Cognitive Health.
    Tangney CC
    Curr Nutr Rep; 2014 Mar; 3(1):51-61. PubMed ID: 25599006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical features of sporadic and familial Alzheimer's disease.
    Rossor MN; Fox NC; Freeborough PA; Harvey RJ
    Neurodegeneration; 1996 Dec; 5(4):393-7. PubMed ID: 9117552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood-based biomarkers of microvascular pathology in Alzheimer's disease.
    Ewers M; Mielke MM; Hampel H
    Exp Gerontol; 2010 Jan; 45(1):75-9. PubMed ID: 19782124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological markers as outcome measures for Alzheimer's disease interventions--real problems and future possibilities.
    Takeda M; Okochi M; Tagami S; Tanaka T; Kudo T
    Int Psychogeriatr; 2007 Jun; 19(3):391-400. PubMed ID: 17391572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin D basis of Alzheimer's disease: from genetics to biomarkers.
    Dursun E; Gezen-Ak D
    Hormones (Athens); 2019 Mar; 18(1):7-15. PubMed ID: 30484096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelets, lymphocytes and erythrocytes from Alzheimer's disease patients: the quest for blood cell-based biomarkers.
    Pluta R; Ułamek-Kozioł M; Januszewski S; Czuczwar SJ
    Folia Neuropathol; 2018; 56(1):14-20. PubMed ID: 29663736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.